NO304227B1 - Substituerte imidazolderivater, preparat som inneholder disse og deres anvendelse - Google Patents

Substituerte imidazolderivater, preparat som inneholder disse og deres anvendelse

Info

Publication number
NO304227B1
NO304227B1 NO942335A NO942335A NO304227B1 NO 304227 B1 NO304227 B1 NO 304227B1 NO 942335 A NO942335 A NO 942335A NO 942335 A NO942335 A NO 942335A NO 304227 B1 NO304227 B1 NO 304227B1
Authority
NO
Norway
Prior art keywords
compounds
pct
inden
dihydro
imidazole
Prior art date
Application number
NO942335A
Other languages
English (en)
Norwegian (no)
Other versions
NO942335L (no
NO942335D0 (no
Inventor
Arto Johannes Karjalainen
Raimo Einari Virtanen
Arja Leena Karjalainen
Maire Marjatta Eloranta
Jarmo Sakari Salonen
Hannu Tapani Sipilo
Antti Sakari Haapalinna
Original Assignee
Juvantia Pharma Ltd Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Juvantia Pharma Ltd Oy filed Critical Juvantia Pharma Ltd Oy
Publication of NO942335D0 publication Critical patent/NO942335D0/no
Publication of NO942335L publication Critical patent/NO942335L/no
Publication of NO304227B1 publication Critical patent/NO304227B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Resins (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO942335A 1991-12-20 1994-06-17 Substituerte imidazolderivater, preparat som inneholder disse og deres anvendelse NO304227B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919127050A GB9127050D0 (en) 1991-12-20 1991-12-20 Substituted imidazole derivatives and their preparation and use
PCT/FI1992/000349 WO1993013074A1 (fr) 1991-12-20 1992-12-18 Derives d'imidazole substitue, leur preparation et leur utilisation

Publications (3)

Publication Number Publication Date
NO942335D0 NO942335D0 (no) 1994-06-17
NO942335L NO942335L (no) 1994-06-20
NO304227B1 true NO304227B1 (no) 1998-11-16

Family

ID=10706581

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942335A NO304227B1 (no) 1991-12-20 1994-06-17 Substituerte imidazolderivater, preparat som inneholder disse og deres anvendelse

Country Status (17)

Country Link
US (1) US5498623A (fr)
EP (1) EP0618906B1 (fr)
JP (1) JP3276371B2 (fr)
AT (1) ATE165350T1 (fr)
AU (1) AU664584B2 (fr)
CA (1) CA2117305C (fr)
DE (1) DE69225240T2 (fr)
DK (1) DK0618906T3 (fr)
ES (1) ES2115046T3 (fr)
FI (1) FI104968B (fr)
GB (1) GB9127050D0 (fr)
HK (1) HK1008962A1 (fr)
HU (1) HU220043B (fr)
NO (1) NO304227B1 (fr)
PL (1) PL172532B1 (fr)
RU (1) RU2120440C1 (fr)
WO (1) WO1993013074A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9312669D0 (en) * 1993-06-18 1993-08-04 Orion Yhtymae Oy New opticla isomers
FR2735776B1 (fr) * 1995-06-22 1997-07-18 Synthelabo Derives de 2,3-dihydro-1h-indole, leur preparation et leur application en therapeutique
GB9520150D0 (en) * 1995-10-03 1995-12-06 Orion Yhtymae Oy New imidazole derivatives
US20020143007A1 (en) * 1996-02-02 2002-10-03 Garvey David S. Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use
US6469065B1 (en) 1996-02-02 2002-10-22 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist, compositions and methods of use
FI20000073A0 (fi) * 2000-01-14 2000-01-14 Orion Yhtymae Oy Uusia imidatsolijohdannaisia
US6388090B2 (en) 2000-01-14 2002-05-14 Orion Corporation Imidazole derivatives
US8188126B2 (en) 2002-05-16 2012-05-29 Pierre Fabre Medicament Imidazolic compounds and use thereof as alpha-2 adrenergic receptors
FI20022007A0 (fi) * 2002-11-08 2002-11-08 Juvantia Pharma Ltd Oy Oromukosaalinen valmiste ja menetelmä sen valmistamiseksi
GB0226076D0 (en) * 2002-11-08 2002-12-18 Rp Scherer Technologies Inc Improved formulations containing substituted imidazole derivatives
EP2456749B1 (fr) 2009-07-24 2016-03-30 DSM Pharma Chemicals Regensburg GmbH Dérivés d'indane à utiliser en tant qu'intermédiaires
WO2011014613A2 (fr) * 2009-07-31 2011-02-03 Dr. Reddy's Laboratories Ltd. Préparation du fipamézole
EP2502917A1 (fr) 2011-03-17 2012-09-26 Santhera Pharmaceuticals (Schweiz) AG Formes cristallines à l'état solide de 4-(2-ethyl-5-fluoro-2,3-dihydro-1H-inden-2-yl)-1H-imidazole
EP3370718B1 (fr) * 2015-11-05 2021-01-27 University Of Louisville Research Foundation, Inc. Anesthésie et analgésie locales et régionales
WO2024160908A1 (fr) * 2023-02-01 2024-08-08 Univerza V Ljubljani N, n-dialkyl-4-(2-éthylindan-2-yl)-1h-imidazole-1-carboxamides et composés apparentés pour le traitement de maladies neurodégénératives
LU103072B1 (en) * 2023-02-15 2024-08-19 Univ Ljubljani N,N-DIALKYL-4-(2-ETHYLINDAN-2-YL)-lH-IMIDAZOLE-l-CARBOXAMIDES AND RELATED COMPOUNDS FOR TREATMENT OF NEURODEGENERATIVE DISEASES

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1282535A (en) * 1970-03-02 1972-07-19 Pfizer (2-IMIDAZOLIN-2-YLAMINO)SUBSTITUTED BENZO[b]THIOPHENES
US3927023A (en) * 1974-05-24 1975-12-16 Warner Lambert Co Imidazolyl benzofurans
US3927018A (en) * 1974-12-23 1975-12-16 Sandoz Ag 3-(2-Methyl-1-imidazolyl)-3-phenyl-1-(3H)isobenzofuranones
IL66242A0 (en) * 1981-07-23 1982-11-30 Erba Farmitalia N-imidazolyl derivatives of 1,2,3,4-tetrahydro-naphthalene,indan and 2-substituted-1-chroman,their preparation and pharmaceutical compositions containing them
NZ201219A (en) * 1981-07-28 1984-10-19 Reckitt & Colmann Prod Ltd Dihydrobenzofuranyl-2-imidazolines and pharmaceutical compositions
ES523609A0 (es) * 1982-07-05 1985-03-01 Erba Farmitalia Procedimiento para preparar derivados n-imidazolilicos de compuestos biciclicos.
GB8409884D0 (en) * 1984-04-17 1984-05-31 Detexomat Machinery Ltd Transporting fabric pieces
GB2167408B (en) * 1984-11-23 1988-05-25 Farmos Oy Substituted imidazole derivatives and their preparation and use
FI81092C (fi) * 1986-05-15 1990-09-10 Farmos Oy Foerfarande foer framstaellning av terapeutiskt aktiva 4(5)-(2,3-dihydro-1h-inden-2-yl)-imidazolderivat.
JP2855341B2 (ja) * 1988-06-10 1999-02-10 武田薬品工業株式会社 新規２―置換クマラン誘導体
IL91542A0 (en) * 1988-10-06 1990-04-29 Erba Carlo Spa N-imidazolyl-and n-imidazolyl-methyl derivatives of substituted bicyclic compounds,their preparation and pharmaceutical compositions containing them
GB2225782A (en) * 1988-12-09 1990-06-13 Farmos Group Limited Imidazole derivatives useful for treatment of diabetes
GB9020128D0 (en) * 1990-09-14 1990-10-24 Reckitt & Colmann Prod Ltd Imidazoline derivatives
AU677171B2 (en) * 1991-12-23 1997-04-17 Mobil Oil Corporation Low oxygen transmissive film
GB9127430D0 (en) * 1991-12-27 1992-02-19 Scras Benzofuranylimidazole derivatives

Also Published As

Publication number Publication date
NO942335L (no) 1994-06-20
FI942882A (fi) 1994-06-16
HU220043B (hu) 2001-10-28
JP3276371B2 (ja) 2002-04-22
ES2115046T3 (es) 1998-06-16
AU3160593A (en) 1993-07-28
FI104968B (fi) 2000-05-15
DE69225240D1 (de) 1998-05-28
RU94031215A (ru) 1996-04-20
HK1008962A1 (en) 1999-05-21
NO942335D0 (no) 1994-06-17
ATE165350T1 (de) 1998-05-15
US5498623A (en) 1996-03-12
CA2117305C (fr) 2003-11-25
RU2120440C1 (ru) 1998-10-20
DK0618906T3 (da) 1999-01-25
GB9127050D0 (en) 1992-02-19
EP0618906A1 (fr) 1994-10-12
AU664584B2 (en) 1995-11-23
CA2117305A1 (fr) 1993-07-08
JPH07506087A (ja) 1995-07-06
EP0618906B1 (fr) 1998-04-22
WO1993013074A1 (fr) 1993-07-08
FI942882A0 (fi) 1994-06-16
HU9401823D0 (en) 1994-09-28
DE69225240T2 (de) 1998-08-27
HUT67548A (en) 1995-04-28
PL172532B1 (en) 1997-10-31

Similar Documents

Publication Publication Date Title
NO304227B1 (no) Substituerte imidazolderivater, preparat som inneholder disse og deres anvendelse
NO986055D0 (no) Nye heterocykliske forbindelser, deres fremstilling, farmas÷ytiske preparat
DK0889877T3 (da) Meta-substituerede phenylenderivater og deres anvendelse som alfav-beta3-integrin-antagonister eller -inhibitorer
DE69713582D1 (de) Zimtsäurederivate und deren verwendung als integrin-antagonisten
PT641328E (pt) Derivados aza-biciclicos em ponte como antagonistas da substancia p
DK0880517T3 (da) Quinazolin-forbindelser
DK0607193T3 (da) Antifugale triazolderivater
NO963706L (no) Benzenkondenserte heterosykliske derivater og deres anvendelse
NO20040589L (no) Arylsulfonylderivater med 5-HT6 reseptor affinitet.
DK1165544T3 (da) Substituerede 1,4-dihydroindeno[1,2-c]pyrazoler som inhibitorer af tyrosinkinase
NO963331L (no) 5-Heteroarylindol-derivater som benzodiazepin-reseptorsete-agonister og antagonister
DK0720598T3 (da) Phenoxyphenylcyclopentenyl-hydroxyurinstoffer
IL87174A (en) Benzimidazole derivatives, their preparation and pharmaceutical compositions containing them
DE69318715D1 (de) Pharmakologisch aktive alpha-(tertiär-aminoethyl)-phenylmethanol-derivate
NO20022971L (no) Butyndiol-derivater
FI955707A (fi) Indolijohdannaiset steroidi-5alfa-reduktaasin inhibiittoreina
UA27738C2 (uk) 2,3,4,5,6,7-гексагідро-1-[4-[1-[4-(2метоксифеніл)піперазиніл]]-2-фенілбутирил]-1н-азепін або його фармацевтично прийнятна кислотно-адитивна сіль, що мають властивість пов'язувати рецептор 5нт1а, спосіб (варіанти) їх одержання, фармацевтична композиція

Legal Events

Date Code Title Description
MK1K Patent expired